Antibiotic-loaded polypropylene surgical meshes with suitable biological behaviour by plasma functionalization and polymerization
Author
Publication date
2015-12ISSN
0142-9612
Abstract
Hernia repair is one of the most common operations in general surgery, and its associated complications typically relate to infections, among others. The loading of antibiotics to surgical meshes to deliver them locally in the abdominal hernia repair site can be one way to manage infections associated with surgical implants. However, the amount of drug loaded is restricted by the low wettability of polypropylene (PP). In this work, plasma has been used to tailor the surface properties of PP meshes to obtain high loading of ampicillin while conserving the desired biological properties of the unmodified samples and conferring them with antibacterial activity. It was demonstrated that the new surface chemistry and improved wettability led to 3-fold higher antibiotic loading. Subsequently, a PEG-like dry coating was deposited from tetraglyme with low-pressure plasma which allowed maintaining the high drug loading and kept cell properties such as chemotaxis, adhesion and morphology to the same levels as the untreated ones which have shown long-standing clinical success.
Document Type
Article
Document version
Accepted version
Language
English
Subject (CDU)
61 - Medical sciences
Keywords
Pages
39
Publisher
Elsevier
Collection
71;
Is part of
Biomaterials
Recommended citation
Labay, Cédric Pierre; Canal Arias, José María; Modic, Martina [et al.]. Antibiotic-loaded polypropylene surgical meshes with suitable biological behaviour by plasma functionalization and polymerization. Biomaterials, 2015, 71, p. 132-144. Disponible en: <https://www.sciencedirect.com/science/article/pii/S0142961215006894?via%3Dihub>. Fecha de acceso: 8 may. 2020. DOI: 10.1016/j.biomaterials.2015.08.023
Note
Authors acknowledge L’Oreal-Unesco programme for Women in Science, the Spanish Government for financial support through Ramon y Cajal fellowship of CC, Generalitat de Catalunya through SGR 2014-1075 and SGR 2014-1333, the Slovenian Research Agency (ARRS) and the European Commission through Cost Action MP1101 “Bioplasmas”.
This item appears in the following Collection(s)
- Ciències de la Salut [973]
Rights
© 2015 Elsevier Ltd. All rights reserved.

